MTOR and neoplasm: In tumors, loss-of-function mutations in the tumor suppressor gene PTEN impair its negative regulatory effects on PI3K signaling, leading to decreased PI3K degradation and sustained phosphorylation-driven activation of Akt and mTOR (Steelman et al., 2004; Chen et al., 2018).